Literature DB >> 25925166

Partial skull base tumour resection in combination with radiosurgery: an escape procedure or a reasonable solution of treatment?

Gorazd Bunc1, Janez Ravnik1, Maja Ravnik2, Tomaz Velnar3,4.   

Abstract

Despite advancement in microsurgical techniques for skull base tumour surgery, approaches of this kind still represent a significant challenge for neurosurgeons due to the size of the tumour and its interference and proximity to important neural and vascular structures. After incomplete resection, gamma knife radiosurgery is becoming an alternative or adjunctive treatment option. In this article, some examples of our experience in combined treatment of the skull base tumours with surgical procedure and gamma knife therapy for the remaining tumour tissue are presented.

Entities:  

Keywords:  Radiosurgery; Residual tumour; Skull base; Surgery; Tumour resection

Mesh:

Year:  2015        PMID: 25925166     DOI: 10.1007/s00508-015-0787-6

Source DB:  PubMed          Journal:  Wien Klin Wochenschr        ISSN: 0043-5325            Impact factor:   1.704


  31 in total

1.  μMLC-LINAC radiosurgery for intracranial meningiomas of complex shape.

Authors:  Faycal El Majdoub; Moataz Elawady; Christian Bührle; Mustapha El-Khatib; Mauritius Hoevels; Harald Treuer; Rolf-Peter Müller; Volker Sturm; Mohammad Maarouf
Journal:  Acta Neurochir (Wien)       Date:  2012-04       Impact factor: 2.216

2.  Petroclival meningiomas: study on outcomes, complications and recurrence rates.

Authors:  Anil Nanda; Vijayakumar Javalkar; Anirban Deep Banerjee
Journal:  J Neurosurg       Date:  2010-12-24       Impact factor: 5.115

Review 3.  [Gamma knife radiosurgery].

Authors:  N Massager
Journal:  Rev Med Brux       Date:  2012-09

4.  Stereotactic LINAC radiosurgery for incompletely resected or recurrent atypical and anaplastic meningiomas.

Authors:  Mustapha El-Khatib; Faycal El Majdoub; Mauritius Hoevels; Martin Kocher; Rolf-Peter Müller; Hans-Jakob Steiger; Volker Sturm; Mohammad Maarouf
Journal:  Acta Neurochir (Wien)       Date:  2011-06-25       Impact factor: 2.216

5.  Preservation of cranial nerve function following Gamma Knife radiosurgery for benign skull base meningiomas: experience in 121 patients with follow-up of 5 to 9.8 years.

Authors:  S Eustacchio; M Trummer; I Fuchs; O Schröttner; B Sutter; G Pendl
Journal:  Acta Neurochir Suppl       Date:  2002

Review 6.  Meningiomas of the basal posterior fossa. Surgical experience in 80 cases.

Authors:  R D Lobato; P Gonzaáez; R Alday; A Ramos; A Lagares; J F Alen; J C Palomino; P Miranda; A Perez-Nuñez; I Arrese
Journal:  Neurocirugia (Astur)       Date:  2004-12       Impact factor: 0.553

7.  Gamma-knife radiosurgery for cranial base meningiomas: experience of tumor control, clinical course, and morbidity in a follow-up of more than 8 years.

Authors:  Iris Zachenhofer; Stefan Wolfsberger; Martin Aichholzer; Alexander Bertalanffy; Karl Roessler; Klaus Kitz; Engelbert Knosp
Journal:  Neurosurgery       Date:  2006-01       Impact factor: 4.654

8.  Gamma knife radiosurgery of skull base meningiomas.

Authors:  M Aichholzer; A Bertalanffy; W Dietrich; K Roessler; W Pfisterer; K Ungersboeck; K Heimberger; K Kitz
Journal:  Acta Neurochir (Wien)       Date:  2000       Impact factor: 2.216

Review 9.  Intradural microsurgery and extradural gamma knife surgery for hypoglossal schwannoma: case report and review of the literature.

Authors:  A Tucker; H Miyake; M Tsuji; T Ukita; K Nishihara; T Ohmura
Journal:  Minim Invasive Neurosurg       Date:  2007-12

Review 10.  Radiosurgery with photons or protons for benign and malignant tumours of the skull base: a review.

Authors:  Maurizio Amichetti; Dante Amelio; Giuseppe Minniti
Journal:  Radiat Oncol       Date:  2012-12-14       Impact factor: 3.481

View more
  1 in total

1.  Metastasis of an occult pulmonary carcinoma into meningioma: a case report.

Authors:  Janez Ravnik; Maja Ravnik; Gorazd Bunc; Ivana Glumbic; Erzebet Tobi-Veres; Tomaz Velnar
Journal:  World J Surg Oncol       Date:  2015-10-05       Impact factor: 2.754

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.